Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19

MeSH terms

• Antihypertensive Agents / therapeutic use
• COVID-19* / diagnosis
• COVID-19* / epidemiology
• COVID-19* / physiopathology
• COVID-19* / therapy
• Calcium Channel Blockers / therapeutic use*
• Comorbidity
• Correlation of Data
• Dihydropyridines / therapeutic use*
• Female
• Humans
• Hypertension / drug therapy*
• Hypertension / epidemiology
• Hypoxia* / etiology
• Hypoxia* / physiopathology
• Hypoxia* / prevention & control
• Male
• Middle Aged
• Proportional Hazards Models
• Retrospective Studies
• SARS-CoV-2 / isolation & purification
• United States / epidemiology
• Vasoconstriction / drug effects*
• Withholding Treatment / statistics & numerical data